DBV Technologies (DBVT) Tax Provisions (2020 - 2026)
DBV Technologies (DBVT) posted quarterly Tax Provisions of $200000.0 for Q2 2026, up 100.0% year-on-year from $100000.0 in Q2 2025, and little changed on a QoQ basis from $200000.0 in Q1 2026.
DBV Technologies (DBVT) Tax Provisions (2020 - 2026) Analysis & Trends
DBV Technologies (DBVT) has reported Tax Provisions for 7 consecutive years, with $200000.0 the latest figure, recorded in Q2 2026.
- Quarterly Tax Provisions rose 100.0% year-over-year to $200000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $774000.0 (up 623.36% YoY) and the FY2025 annual result came in at $491000.0, up 792.73% from the prior year.
- Tax Provisions was little changed at $200000.0 in Q2 2026 per DBVT's latest filing, from $200000.0 in the prior quarter.
- Over the last five years, Tax Provisions for DBVT reached as high as $374000.0 in Q4 2025 and fell as low as -$17000.0 in Q4 2022.
- A 5-year average of $100600.0 and a median of $67500.0 in 2022 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2022 — Tax Provisions slumped 173.91% — and 2025, when it jumped 5242.86%.
- Year by year, Tax Provisions stood at -$17000.0 in 2022, then surged by 64.71% to -$6000.0 in 2023, then soared by 216.67% to $7000.0 in 2024, then soared by 5242.86% to $374000.0 in 2025, then tumbled by 46.52% to $200000.0 in 2026.
- According to Business Quant data, Tax Provisions over the past three periods registered $200000.0, $200000.0, and $374000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 31.86 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | DBV Technologies | 267.50 Mn | 92.60 Mn | - | 200,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 200,000.00 |
| Mar 31, 2026 | 200,000.00 |
| Dec 31, 2025 | 374,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Dec 31, 2024 | 7,000.00 |
| Mar 31, 2024 | 48,000.00 |
| Dec 31, 2023 | -6,000.00 |
| Jun 30, 2023 | 13,000.00 |
| Dec 31, 2022 | -17,000.00 |
| Mar 31, 2022 | 87,000.00 |
| Dec 31, 2021 | 23,000.00 |
| Jun 30, 2021 | -434,000.00 |
| Mar 31, 2021 | 30,000.00 |
| Dec 31, 2020 | -20,000.00 |
| Sep 30, 2020 | 7,000.00 |
| Jun 30, 2020 | 3,000.00 |